Charles River Laboratories CRL Payments to Acquire Investments
Payments to Acquire Investments at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's payments to acquire investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's payments to acquire investments?
- Charles River Laboratories (CRL) reported payments to acquire investments of $8.49M in Q1 2026.
- How has Charles River Laboratories's payments to acquire investments changed year-over-year?
- Charles River Laboratories's payments to acquire investments increased by 60.2% year-over-year, from $5.3M to $8.49M.
- What is the long-term trend for Charles River Laboratories's payments to acquire investments?
- Over 4 years (2021 to 2025), Charles River Laboratories's payments to acquire investments has grown at a -18.5% compound annual growth rate (CAGR), from $45.56M to $20.08M.
- What does payments to acquire investments mean?
- Cash used to purchase financial investments or stakes in other companies.
- How do you interpret payments to acquire investments?
- An increase suggests a strategy of deploying capital into external financial assets, whereas a decrease may indicate a focus on internal operations or debt reduction.
- How does payments to acquire investments compare across companies?
- Standard line item in the investing section of the cash flow statement for companies with active treasury or corporate development functions.